Medindia
About ▼ Careers Internship MedBlog Contact us
English (US) ▼
Medindia
LOGIN REGISTER
Advertisement

Genomic Health and Cleveland Diagnostics Announce Strategic Collaboration to Develop and Commercialize New Prostate Cancer Tests

Tuesday, November 28, 2017 Cancer News
Advertisement
Global Licensing Agreement Provides Genomic Health with Exclusive Rights to Cleveland Diagnostics' Proprietary IsoPSA™ Technology

Sponsored Post and Backlink Submission


Latest Press Release on Cancer News

Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb
USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC , May 9, 2024 /PRNewswire/ -- In the fight against cancer, a political stumbling...
Infinitopes' Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
Publication in Human Vaccines and Immunotherapeutics highlights progress in understanding tumour biology and vaccine technologies since the pandemic OXFORD, England , May 9, 2...
Commit Biologics launches with €16m seed financing to pioneer complement system activation to treat cancer and autoimmune disease
Financing led by Bioqube Ventures and Novo Holdings Commit is pioneering a novel approach to activating the complement component of the immune system to treat cancer and autoimmun...
Debbie's Dream Foundation: Curing Stomach Cancer Supports Pioneering Gastroesophageal Cancer Research Retreat
DDF invites the stomach cancer community to participate in the live Patient Advocacy and Case Discussion via Zoom. NEW YORK , May 8, 2024 /PRNewswire/ -- Debbie's Dream Founda...
Acepodia Announces Preliminary Clinical Data From Phase 1 Clinical Trial of ACE1831, First-Ever Anti-CD20 Antibody Conjugated Allogenic Gamma Delta T Cell Therapy for Non-Hodgkins Lymphoma
First dosing dohort was completed with complete response and disease stabilization identified at three months at the lowest dose level in the Phase 1 study No ACE1831-related serio...
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close